• Explore /
  • Poster
  • / Serial circulating tumor DNA (ctDNA) analysis as a prognostic marker and a real-time indicator of adjuvant chemotherapy (CT) efficacy in stage III colon cancer (CC).

Serial circulating tumor DNA (ctDNA) analysis as a prognostic marker and a real-time indicator of adjuvant chemotherapy (CT) efficacy in stage III colon cancer (CC).

Abstract Poster

Authors

Jeanne Tie

Jeanne Tie

The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

Jeanne Tie , Joshua Cohen , Yuxuan Wang , Margaret Lee , Rachel Wong , Suzanne Kosmider , Sumitra Ananda , Jin Hee Cho , Ian Faragher , Joseph James McKendrick , Carmela Corfield , Belinda Lee , Kathryn Maree Field , Ian Jones , Lu Li , Cristian Tomasetti , Nickolas Papadopoulos , Kenneth W. Kinzler , Bert Vogelstein , Peter Gibbs

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Epidemiology/Outcomes

Citation

J Clin Oncol 36, 2018 (suppl; abstr 3516)

DOI

10.1200/JCO.2018.36.15_suppl.3516

Abstract #

3516

Poster Bd #

9

Abstract Disclosures

Similar Posters

First Author: Romain Cohen

First Author: Harry H. Yoon

First Author: Thomas Aparicio

First Author: John Souglakos